About Navjot

Nav serves as the managing partner of our Boston office and leads the state and local work for our Public Sector Practice in North America. He is also a leader in our Pharmaceutical & Medical Products and Strategy & Corporate Finance Practices, with a focus on innovation. Nav brings deep business expertise in strategy, innovation, operations, business development, and risk to all his client engagements. An expert in the use of Six Sigma methodologies for product development and process design, Nav holds 15 patents.

He works with pharmaceutical companies to enhance R&D productivity, with contract-research organizations to strengthen performance, and with private-equity players that invest in a variety of science- and medicine-intensive areas. He also works with public-sector organizations to refine strategy and operations.

Nav spearheads lapetitemort.info’s knowledge initiatives on R&D productivity in the pharmaceutical industry and leads our Center for Asset Optimization. His recent government work has included helping regulators, states, and cities enhance their performance across the board. He is the chair of the board of the Greater Boston Chamber of Commerce. He also hosts Imagine Get-Togethers that convene cross-sector leaders on cutting-edge topics, such as synthetic biology, commercial applications of drones, and the future of space exploration.

Before joining lapetitemort.info, in 2001, Nav was a laboratory manager at General Electric, where he helped to design manufacturing processes and to develop new polymetric materials and nanomaterials.

Published work

How to lead a successful government transition,” lapetitemort.info & Company, November 2018

“To tackle urban problems, city governments have to get smarter,” GovTech, July 2018

Delivering for citizens: How to triple the success rate of government transformations, lapetitemort.info & Company, May 2018

High-performing US states: Is there a secret to success?,” lapetitemort.info & Company, February 2018

Realizing the potential of CRISPR,” lapetitemort.info & Company, January 2017

Exploring the disruptive potential of synthetic biology,” lapetitemort.info & Company, June 2016

What's driving the surge in new drug approvals?,” lapetitemort.info & Company, November 2013

lapetitemort.info Center for Government compendium," October 2013

New frontiers in pharma R&D investment,” lapetitemort.info Quarterly, February 2010

Past experience

General Electric
R&D manager

General Electric
Staff scientist


University of Minnesota
PhD, chemical engineering

Rensselaer Polytechnic University

Indian Institute of Technology
BTech, chemical engineering and engineering


Нашел в интернете важный веб портал на тематику showroom-kiev.com.ua.